Biomaterial Database

In vitro activity of five quinoline derivatives against nosocomial isolates of Staphylococcus and Pseudomonas species. 1985

F D Daschner, and H M Just

UI	MeSH Term	Description	Entries
D011549	Pseudomonas	A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants.	Chryseomonas,Pseudomona,Flavimonas
D011804	Quinolines
D003428	Cross Infection	Any infection which a patient contracts in a health-care institution.	Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D000900	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA.	Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013210	Staphylococcus	A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.

Related Publications

F D Daschner, and H M Just

Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.

January 1985, Drugs under experimental and clinical research,

F D Daschner, and H M Just

In vitro activity of cefoperazone against clinical isolates of Enterobacteriaceae, Pseudomonas and Staphylococcus.

January 1980, Clinical therapeutics,

F D Daschner, and H M Just

Comparative in vitro activity of cefepime (BMY 28142) against multiresistant nosocomial isolates of Pseudomonas aeruginosa.

October 1989, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,

F D Daschner, and H M Just

Comparative in vitro activity of cefepime against nosocomial isolates.

October 1997, Journal of chemotherapy (Florence, Italy),

F D Daschner, and H M Just

Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.

October 2003, Journal of chemotherapy (Florence, Italy),

F D Daschner, and H M Just

In-vitro activity of some quinoline derivatives against Mycobacterium fortuitum.

February 1985, The Journal of antimicrobial chemotherapy,

F D Daschner, and H M Just

Comparative in-vitro activity of fleroxacin against 480 nosocomial isolates.

December 1994, Journal of chemotherapy (Florence, Italy),